Perrigo Company plc (PRGO) Stock Analysis

Why this analysis is different

• A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
• An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
• Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

Perrigo Company plc (PRGO) Healthcare & Pipeline Overview

Perrigo Company plc is a leading provider of over-the-counter (OTC) health and wellness solutions, operating through its Consumer Self-Care Americas and International segments. With a focus on store-brand products and well-known brands like Prevacid 24HR and Burt's Bees, Perrigo empowers consumers to self-manage their health across various categories and geographies.

What Is the Investment Thesis for PRGO?

Perrigo Company plc presents a mixed investment thesis. The company's established presence in the OTC market and diverse product portfolio provide a stable revenue base. The dividend yield of 9.91% may attract income-focused investors. However, the negative profit margin of -43.5% raises concerns about profitability and operational efficiency. Future growth will depend on Perrigo's ability to innovate and expand its product offerings, particularly in the Consumer Self-Care Americas segment. The company's beta of 0.49 suggests lower volatility compared to the broader market. Investors should closely monitor Perrigo's efforts to improve profitability and manage its cost structure. Upcoming catalysts include potential new product launches and expansion into new geographic markets. Potential risks include increased competition in the OTC market and regulatory changes.

Based on FMP financials and quantitative analysis

PRGO Key Highlights

Perrigo operates in two segments: Consumer Self-Care Americas and Consumer Self-Care International, providing diversification across geographies.

• The company offers a wide range of OTC products, including upper respiratory, pain and sleep aids, digestive health, and skincare.
• Perrigo's Consumer Self-Care Americas segment includes well-known brands such as Prevacid 24HR and Burt's Bees.
• The company distributes its products through a network of pharmacies, wholesalers, drug and grocery store retailers, and para-pharmacies.
• Perrigo provides contract manufacturing services, leveraging its production capabilities.

Who Are PRGO's Competitors?

PRGO is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance This table mixes two scoring engines — compare a number only with others carrying the same tag.

What Are PRGO's Key Strengths?

Established presence in the OTC market

• Diverse product portfolio
• Strong distribution network
• Well-known brands

What Are PRGO's Weaknesses?

Negative profit margin

• Dependence on store-brand products
• Exposure to regulatory risks
• Intense competition

What Could Drive PRGO Stock Higher?

Potential new product launches in the Consumer Self-Care Americas segment.

• Expansion into new geographic markets in the Consumer Self-Care International segment.
• Increased focus on e-commerce and digital channels to drive sales.
• Strategic acquisitions and partnerships to expand product portfolio.

What Are the Key Risks for PRGO?

Financial-distress signal — its Altman Z-Score of -0.38 sits in the distress zone (elevated bankruptcy risk).

• Negative return on equity (-50.7%) — the business is not currently generating profit on shareholder capital.
• Increased competition in the OTC market.
• Regulatory changes impacting the OTC industry.
• Pricing pressures from retailers and distributors.
• Economic downturn affecting consumer spending on OTC products.
• Negative profit margin impacting financial performance.

What Are the Growth Opportunities for PRGO?

• Expansion in the Consumer Self-Care Americas Segment: Perrigo can further expand its presence in the Americas by introducing new products and expanding its distribution network. The market for OTC products in the United States, Mexico, Canada, and South America is substantial, offering significant growth potential. Perrigo can leverage its existing brands and develop new products to meet the evolving needs of consumers. Timeline: Ongoing.
• Growth in the Consumer Self-Care International Segment: Perrigo can continue to grow its international business by expanding into new markets and increasing its market share in existing markets. The company's presence in approximately 23 countries in Europe provides a solid foundation for further expansion. Perrigo can adapt its product offerings to meet the specific needs of consumers in different countries. Timeline: Ongoing.
• New Product Development and Innovation: Perrigo can drive growth by investing in research and development to create new and innovative OTC products. The company can focus on developing products that address unmet needs in the market and provide consumers with effective self-care solutions. This includes exploring new therapeutic areas and delivery methods. Timeline: Ongoing.
• Strategic Acquisitions and Partnerships: Perrigo can pursue strategic acquisitions and partnerships to expand its product portfolio and geographic reach. The company can acquire complementary businesses or partner with other companies to gain access to new technologies and markets. This can accelerate growth and enhance Perrigo's competitive position. Timeline: Ongoing.
• Increased Focus on E-commerce and Digital Channels: Perrigo can capitalize on the growing trend of online shopping by increasing its focus on e-commerce and digital channels. The company can partner with online retailers and develop its own e-commerce platform to reach a wider audience of consumers. This can drive sales and improve brand awareness. Timeline: Ongoing.

What Are PRGO's Competitive Advantages?

• Established presence in the OTC market.
• Diverse product portfolio across multiple categories.
• Strong relationships with retailers and distributors.
• Well-known brands such as Prevacid 24HR and Burt's Bees.
• Contract manufacturing capabilities.

What Does PRGO Do?

Founded in 1887 and headquartered in Dublin, Ireland, Perrigo Company plc has evolved into a global provider of over-the-counter (OTC) health and wellness solutions. The company operates through two primary segments: Consumer Self-Care Americas and Consumer Self-Care International. The Consumer Self-Care Americas segment focuses on the development, manufacture, marketing, and sale of store-brand self-care products in the United States, Mexico, Canada, and South America. This segment offers products across a wide range of categories, including upper respiratory, pain and sleep aids, digestive health, nutrition, vitamins, minerals and supplements, healthy lifestyle, skincare and personal hygiene, and oral self-care. Key brands within this segment include Prevacid 24HR, Good Sense, Zephrex D, ScarAway, Plackers, Rembrandt, Steripod, Firefly, REACH, Dr. Fresh, and Burt's Bees. The Consumer Self-Care International segment develops, manufactures, markets, and distributes consumer self-care brands through a network of pharmacies, wholesalers, drug and grocery store retailers, and para-pharmacies in approximately 23 countries, primarily in Europe. Perrigo also offers contract manufacturing services, leveraging its production capabilities to serve other companies in the healthcare space. With a history spanning over a century, Perrigo has established itself as a key player in the OTC market, focusing on providing affordable and accessible self-care solutions to consumers worldwide.

What Products and Services Does PRGO Offer?

• Develop, manufacture, and market over-the-counter (OTC) health and wellness solutions.
• Operate through two segments: Consumer Self-Care Americas and Consumer Self-Care International.
• Offer store-brand self-care products in categories such as upper respiratory, pain and sleep aids, and digestive health.
• Provide nutrition, vitamins, minerals, and supplements.
• Offer skincare and personal hygiene products.
• Provide oral self-care products.
• Distribute products through pharmacies, wholesalers, drug and grocery store retailers, and para-pharmacies.
• Offer contract manufacturing services.

How Does PRGO Make Money?

• Develop, manufacture, and market OTC products under store brands and established brands.
• Generate revenue through the sale of these products to retailers and distributors.
• Offer contract manufacturing services to other companies in the healthcare space.
• Focus on providing affordable and accessible self-care solutions to consumers.

What Industry Does PRGO Operate In?

Perrigo operates in the global over-the-counter (OTC) healthcare market, which is characterized by increasing consumer demand for self-care solutions. The market is driven by factors such as an aging population, rising healthcare costs, and a growing preference for self-medication. Perrigo competes with other major players in the OTC market, including large pharmaceutical companies and consumer goods companies. The company's focus on store-brand products and established brands positions it to capture a significant share of the market. The industry is subject to regulatory oversight and pricing pressures, which can impact profitability.

Who Are PRGO's Key Customers?

• Retailers and distributors in the United States, Mexico, Canada, and South America.
• Pharmacies, wholesalers, drug and grocery store retailers, and para-pharmacies in Europe.
• Consumers who purchase OTC products for self-care.
• Other companies in the healthcare space that utilize Perrigo's contract manufacturing services.

Company Profile

Perrigo Company plc operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Dublin, IE. The company is led by CEO Albert A. Manzone. PRGO has traded publicly since 1991.

Perrigo Company plc Financial Trajectory

Perrigo Company plc (PRGO) reported $1.02B in revenue for Q2 FY2026, reflecting 5.5% growth compared to the prior quarter. The company recorded net income of $74.5M, with diluted EPS of $0.53. Quarter-over-quarter revenue has been mixed, typical for a small-cap company operating in Healthcare. Across the four most recent quarters, PRGO averaged $-3.13 in diluted EPS.

How Perrigo Company plc Is Valued

Perrigo Company plc carries a market capitalization of $1.88B, placing it in the small-cap category. Analyst price targets span from $20.00 to $54.00, with a consensus of $36.20. At the current price of $13.59, that implies approximately 166% upside potential. Relative to its peer group, PRGO's quantitative score of 17/100 is below the peer average of 62/100.

Return on equity for Perrigo Company plc stands at -50.7%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -22.8%, showing how much profit it generates from its asset base. Its free cash flow yield is 8.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 2.72 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -134.3%, the inverse of the P/E and a quick read on earnings relative to price.

Perrigo Company plc's Piotroski F-Score is 5/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of -0.38 places it in the distress zone, a signal of elevated financial risk.

Perrigo Company plc has beaten Wall Street's EPS estimate in 5 of its last 8 reported quarters — more hits than misses. Reported results have landed about 5.7% above estimates on average.

Over the past six months, Perrigo Company plc insiders filed 98 SEC Form 4 transactions — 46 sales and 52 purchases. On net that is roughly 1.4M shares acquired (about $933K) — insiders putting money in tends to read as conviction.

PRGO Financials

PRGO Latest News

PRGO Analyst Consensus

PRGO MoonshotScore

Common Questions About PRGO (Healthcare)

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources